Clinical and epidemiological profile of premature patients in the ambulatory of pediatric ophthalmology of a university health service

Barra lateral de artigos

PDF (English)
Publicado: dez 28, 2020
DOI: https://doi.org/10.7322/abcshs.2020S02.1849
Palavras-chave:
retinopathy, premature, development

Conteúdo do artigo principal

Fabio Naoki Hino
Discipline of Ophthalmology, Centro Universitário FMABC - Santo André (SP), Brazil
Vitório Lauro D’Amico Filho
Discipline of Ophthalmology, Centro Universitário FMABC - Santo André (SP), Brazil
Jéssica Agena
Discipline of Ophthalmology, Centro Universitário FMABC - Santo André (SP), Brazil
Wesley de Paula Duque
Discipline of Ophthalmology, Centro Universitário FMABC - Santo André (SP), Brazil
Vagner Loduca Lima
Discipline of Ophthalmology, Centro Universitário FMABC - Santo André (SP), Brazil

Resumo

Introduction: Retinopathy of prematurity (ROP) is a vasoproliferative disorder of the retina that affects low birth weight preterm babies and is the leading cause of blindness in children in developed and developing countries. Objective: Considering the importance of evaluating the pathology, this study aimed to carry out an epidemiological analysis of premature patients referred to the Pediatric Ophthalmology sector of Centro Universitário FMABC. Methods: Retrospective study of the medical records of patients referred to the Pediatric Ophthalmology sector of Centro Universitário FMABC, from March 2017 to December 2017, for ophthalmological evaluation due to suspected ROP (59 medical records). Results: Of the total of 43 eyes with the disease, two eyes fit in Zone II and 41 in Zone III. Seventeen eyes were classified as Stage 1, 16 as Stage 2, 4 as Stage 3, 4 as Stage 4 and 2 as Stage 5. Conclusion: The development of ROP was inversely proportional to weight and gestational age at birth. Treatment proved to be less prevalent in the disease.

Downloads

Não há dados estatísticos.

Detalhes do artigo

Como Citar
Hino, F. N., D’Amico Filho, V. L. ., Agena, J., Duque, W. de P. ., & Lima, V. L. . (2020). Clinical and epidemiological profile of premature patients in the ambulatory of pediatric ophthalmology of a university health service. ABCS Health Sciences, 45(Suppl.3), e020102. https://doi.org/10.7322/abcshs.2020S02.1849
Edição
v. 45 n. Suppl.3 (2020)
Seção
Artigos Originais

Autores que publicam nesta revista concordam com os seguintes termos:

  1. Autores mantém os direitos autorais e concedem à revista o direito de primeira publicação, com o trabalho simultaneamente licenciado sob uma licença Creative Commons CC BY que permite o compartilhamento e adaptação do trabalho com reconhecimento da autoria e publicação inicial nesta revista.
     
  2. Autores têm autorização para assumir contratos adicionais separadamente, para distribuição não-exclusiva da versão do trabalho publicada nesta revista (ex.: publicar em repositório institucional ou como capítulo de livro), com reconhecimento de autoria e publicação inicial nesta revista.

Referências

1. Hutchinson AK, Melia M, Yang MB, VanderVeen DK, Wilson LB, Lambert SR. Clinical Models and Algorithms for the Prediction of Retinopathy of Prematurity: A Report by the American Academy of Ophthalmology. Ophthalmology. 2016;123(4):804-16. https://doi.org/10.1016/j.ophtha.2015.11.003

2. Swan R, Kim SJ, Campbell JP, Chan RVP, Sonmez K, Taylor KD, et al. The genetics of retinopathy of prematurity: a model for neovascular retinal disease. Ophthalmol Retina. 2018;2(9):949-62. https://doi.org/10.1016/j.oret.2018.01.016

3. Quinn GE, Barr C, Bremer D, Fellows R, Gong A, Hoffman R, et al. Changes in course of retinopathy of prematurity from 1986 to 2013: comparison of three studies in the United States. Ophthalmology. 2016;123(7):1595-1600. https://doi.org/10.1016/j.ophtha.2016.03.026

4. Quinn GE. Retinopathy of prematurity blindness worldwide: phenotypes in the third epidemic. Eye Brain. 2016;8:31-6. https://doi.org/10.2147/EB.S94436

5. Pallot C, Faure AS, Charvy C, Ternoy N, Muteau CL, Acar N, et al. Screening for Retinopathy of Prematurity: Insight into Optimizing Screening. Ophthalmic Res. 2018;59(4):228-34. https://doi.org/10.1159/000477622

6. Suelves AM, Shulman JP. Current screening and treatments in retinopathy of prematurity in the US. Eye Brain. 2016;8:37-43. https://doi.org/10.2147/EB.S94439

7. Reisner SH, Amir J, Shohat M, Krikler R, Nissenkorn I, Ben-Sira I. Retinopathy of prematurity: incidence and treatment. Arch Dis Child. 1985;60(8):698-701. https://doi.org/10.1136/adc.60.8.698

8. Fortes Filho JB, Eckert GU, Valiatti FB, Costa MC, Bonomo PP, Procianoy RS. Prevalência e fatores de risco para a retinopatia da prematuridade: estudo com 450 pré-termos de muito baixo peso. Rev Bras Oftalmol. 2009;68(1):22-9. https://doi.org/10.1590/S0034-72802009000100005